Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
M. Kerkhof (Singapore, Singapore), J. Voorham (Singapore, Singapore), C. Cabrera (Mölndal, Sweden), P. Darken (Morristown, NJ, United States of America), P. Dorinsky (Durham, NC, United States of America), J. Kocks (Singapore, Singapore), M. Sadatsafavi (Vancouver, BC, Canada), D. Sin (Vancouver, BC, Canada), D. Price (Singapore, Singapore)
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Session: Eosinophils and FeNO in airway diseases
Session type: Oral Presentation
Number: 2154
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kerkhof (Singapore, Singapore), J. Voorham (Singapore, Singapore), C. Cabrera (Mölndal, Sweden), P. Darken (Morristown, NJ, United States of America), P. Dorinsky (Durham, NC, United States of America), J. Kocks (Singapore, Singapore), M. Sadatsafavi (Vancouver, BC, Canada), D. Sin (Vancouver, BC, Canada), D. Price (Singapore, Singapore). Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker. 2154
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: